Condition
Unresectable Locally Recurrent Rectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Unresectable Locally Recurrent Rectal Cancer clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Stereotactic body radiation therapy for unresectable locally recurrent rectal cancer
This will try high-precision stereotactic body radiation therapy (SBRT) to control unresectable locally recurrent rectal cancer in adults who cannot have curative surgery.
-
Combining radiation therapy and PD-1 antibody for advanced rectal cancer
This study is testing if combining a special type of radiation therapy with a new immune treatment can help people with advanced rectal cancer live longer and possibly become eligible for surgery.
Quick answers
How many Unresectable Locally Recurrent Rectal Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.